NO20003472D0 - TTS som inneholder en antioksidant - Google Patents

TTS som inneholder en antioksidant

Info

Publication number
NO20003472D0
NO20003472D0 NO20003472A NO20003472A NO20003472D0 NO 20003472 D0 NO20003472 D0 NO 20003472D0 NO 20003472 A NO20003472 A NO 20003472A NO 20003472 A NO20003472 A NO 20003472A NO 20003472 D0 NO20003472 D0 NO 20003472D0
Authority
NO
Norway
Prior art keywords
antioxidant
ethyl
tts containing
tts
carbamate
Prior art date
Application number
NO20003472A
Other languages
English (en)
Other versions
NO20003472L (no
NO328390B1 (no
Inventor
Bodo Asmussen
Michael Horstmann
Kai Koepke
Harry Tiemessen
Original Assignee
Novartis Ag
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003472(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Lohmann Therapie Syst Lts filed Critical Novartis Ag
Publication of NO20003472D0 publication Critical patent/NO20003472D0/no
Publication of NO20003472L publication Critical patent/NO20003472L/no
Publication of NO328390B1 publication Critical patent/NO328390B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
NO20003472A 1998-01-12 2000-07-05 Farmasoytisk sammensetning, anvendelse av antioksidant for a stabilisere nevnte sammensetning, samt transdermal innretning omfattende nevnte sammensetning NO328390B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Publications (3)

Publication Number Publication Date
NO20003472D0 true NO20003472D0 (no) 2000-07-05
NO20003472L NO20003472L (no) 2000-08-07
NO328390B1 NO328390B1 (no) 2010-02-08

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003472A NO328390B1 (no) 1998-01-12 2000-07-05 Farmasoytisk sammensetning, anvendelse av antioksidant for a stabilisere nevnte sammensetning, samt transdermal innretning omfattende nevnte sammensetning

Country Status (26)

Country Link
US (1) US6335031B1 (no)
EP (1) EP1047409B1 (no)
KR (1) KR100569051B1 (no)
CN (1) CN1129427C (no)
AT (1) ATE223711T1 (no)
AU (1) AU745661B2 (no)
BR (1) BR9906920A (no)
CA (1) CA2315784C (no)
CZ (1) CZ300598B6 (no)
DE (1) DE69902875T2 (no)
DK (1) DK1047409T3 (no)
ES (1) ES2184408T3 (no)
GB (1) GB9800526D0 (no)
HK (1) HK1034036A1 (no)
HU (1) HU227159B1 (no)
ID (1) ID27503A (no)
IL (1) IL137100A (no)
MX (1) MXPA00006438A (no)
NO (1) NO328390B1 (no)
NZ (1) NZ505650A (no)
PL (1) PL201328B1 (no)
PT (1) PT1047409E (no)
RU (1) RU2219926C2 (no)
SK (1) SK284622B6 (no)
TR (2) TR200101021T2 (no)
WO (1) WO1999034782A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121104B1 (en) * 1998-10-01 2005-01-12 Novartis AG New controlled release oral formulations for rivastigmine
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
PL198323B1 (pl) * 1999-11-29 2008-06-30 Lohmann Therapie Syst Lts Transdermalny system terapeutyczny zawierający wrażliwe na utlenianie substancje czynne i sposób jego wytwarzania
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
CA2936400C (en) 2008-07-28 2018-03-27 Takeda Pharmaceutical Company Limited Pharmaceutical composition
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
PL2515886T3 (pl) 2009-12-22 2018-08-31 Luye Pharma Ag Przezskórny układ terapeutyczny do podawania rywastygminy lub jej pochodnych
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
EP2596071B1 (en) 2010-07-21 2019-02-13 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
ES2545094T3 (es) 2010-12-14 2015-09-08 Acino Ag Sistema terapéutico transdérmico para la administración de un principio activo
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
WO2012161489A2 (ko) 2011-05-20 2012-11-29 에스케이케미칼 주식회사 리바스티그민 함유 패취
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2594261A1 (en) 2011-11-18 2013-05-22 Labtec GmbH Composition for transdermal administration of rivastigmine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
JP6153135B2 (ja) 2012-06-12 2017-06-28 株式会社 ケイ・エム トランスダーム 貼付剤
JP6269488B2 (ja) * 2012-09-03 2018-01-31 ニプロ株式会社 貼付剤
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
US9895320B2 (en) 2012-09-28 2018-02-20 KM Transderm Ltd. Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
JPWO2015174502A1 (ja) 2014-05-15 2017-05-25 ニチバン株式会社 リバスチグミンを含有する貼付剤のための包装体
KR20200025888A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR20200025883A (ko) 2018-08-31 2020-03-10 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL195004C (nl) * 1987-03-04 2003-11-04 Novartis Ag Fenylcarbamaat bevattend farmaceutisch preparaat.
WO1998030243A1 (en) * 1997-01-08 1998-07-16 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
AU5495398A (en) * 1997-01-17 1998-08-07 Takeda Chemical Industries Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
GB9800526D0 (en) 1998-03-11
PT1047409E (pt) 2002-12-31
RU2219926C2 (ru) 2003-12-27
JP2002500178A (ja) 2002-01-08
ATE223711T1 (de) 2002-09-15
ES2184408T3 (es) 2003-04-01
NO20003472L (no) 2000-08-07
IL137100A0 (en) 2001-06-14
HUP0004300A3 (en) 2003-05-28
IL137100A (en) 2004-12-15
DE69902875T2 (de) 2003-05-22
SK284622B6 (sk) 2005-08-04
ID27503A (id) 2001-04-12
TR200001688T2 (tr) 2000-11-21
CA2315784A1 (en) 1999-07-15
KR100569051B1 (ko) 2006-04-10
EP1047409B1 (en) 2002-09-11
DE69902875D1 (de) 2002-10-17
HUP0004300A2 (hu) 2001-05-28
CZ300598B6 (cs) 2009-06-24
CN1129427C (zh) 2003-12-03
WO1999034782A1 (en) 1999-07-15
CZ20002557A3 (cs) 2000-10-11
US6335031B1 (en) 2002-01-01
MXPA00006438A (es) 2003-07-21
CA2315784C (en) 2006-06-27
TR200101021T2 (tr) 2002-06-21
HK1034036A1 (en) 2001-10-12
PL341347A1 (en) 2001-04-09
CN1288375A (zh) 2001-03-21
AU745661B2 (en) 2002-03-28
HU227159B1 (en) 2010-09-28
AU2278599A (en) 1999-07-26
KR20010033072A (ko) 2001-04-25
BR9906920A (pt) 2000-10-10
PL201328B1 (pl) 2009-03-31
NZ505650A (en) 2002-10-25
SK10532000A3 (sk) 2000-11-07
NO328390B1 (no) 2010-02-08
JP3820103B2 (ja) 2006-09-13
DK1047409T3 (da) 2002-12-30
EP1047409A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
NO20003472D0 (no) TTS som inneholder en antioksidant
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
HRP20080178T3 (en) Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
DK0768896T3 (da) Lavdoserede steroidtabletter, der indeholder gallussyreestere som antioxidant, fremgangsmåde til fremstilling og anvendelse
BR9911960A (pt) Composição medicamentosa autoadesiva, e utilização da mesma
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Legal Events

Date Code Title Description
MK1K Patent expired